The donation of ten lung ventilators by the Chinese Hainergy Corporation, under the Haier Group, will benefit four Havana hospitals in the struggle against COVID-19.

Despite the drop in the number of COVID-19 cases, the province of Matanzas strives to prevent people from underestimating the disease, according to the top local authorities.

Cuban President Miguel Díaz-Canel highlighted today on Twitter the good pace of trials with the Cuban drug NeuroEpo, developed by the Center for Molecular Immunology (CIM) to treat mild and moderate Alzheimer's cases.

Cuba’s Health Ministry takes action towards an ontime response to the challenges facing the planet and its environment, said Ileana Morales, director of Science and Technological Innovation in the sector.

On September 19, 2021, the last patient was included in Phase I of the clinical trial with the anti-SARS-CoV-2 gamma globulin, a research conducted at the Doctor Luis Diaz Soto Military Hospital in Havana, with COVID-19 positive patients over 19 years of age.

Cuba studied a total of 7,641 samples for surveillance during the day, 510 of which were positive. The country accumulates 13,498,857 samples taken and 1,093,676 positive.

Dr. Francisco Duran Garcia, national director of epidemiology of the Cuban ministry of public health (MINSAP by its Spanish acronym), informed today at the usual Monday press conference on the COVID-19 situation in Cuba, that taking into account the high percentage of vaccination achieved so far, the country decided to take a number of measures to make it more flexible for travelers coming from other countries.

Cuba studied a total of 11,272 samples for surveillance during the day, 619 of which were positive. The country accumulates 13,491,216 samples taken and 1,093,166 positive.

The dossier of the anti-COVID-19 vaccine, Abdala, is ready to be reviewed by experts from the World Health Organization (WHO), reported the Cuban Biotechnological and Pharmaceutical Industry Group (BioCubaFarma).

Cuban health ministry (MINSAP by its Spanish acronym) reported today that 89.5 % of the Cuban population (9,914,202 people) has a complete anti-COVID-19 vaccination schedule.

Cuba studied a total of 12,267 samples for surveillance during the day, with 778 positive for 6.3% positivity. The country accumulates 13,454,322 samples taken and 1,091,063 positive (8.1%).

Mambisa is one of Cuba’s two COVID-19 vaccine candidates—the other is Soberana 01—after the Center for State Control of Medicines, Equipment and Medical Devices (CECMED) approved the emergency use of Abdala, Soberana 02 and Soberana Plus.

Ever since the first COVID-19 cases were diagnosed in Cuba, the United Nations Children's Fund (UNICEF) has helped the country’s efforts to keep in place services deemed essential to children, teenagers and pregnant women with foods, syringes, means of protection, refrigerators and vital equipment such as an ambulance, an oxygen plant and high precision ultrasound equipment.

As part of the ongoing International Congress of Researchers about Children, Adolescents and Youths, experts with the National Sexual Education Center (CENESEX), the Center for Studies on Youth (CESJ) and the UN Population Fund (UNFPA) called for the need to prevent adolescent pregnancy.